Core Viewpoint - UMB Financial (UMBF) is currently viewed as a more attractive investment option compared to Commerce Bancshares (CBSH) based on various valuation metrics and earnings outlook [3][7]. Valuation Metrics - UMBF has a forward P/E ratio of 9.68, while CBSH has a forward P/E of 12.46, indicating that UMBF may be undervalued relative to CBSH [5]. - The PEG ratio for UMBF is 0.83, suggesting a favorable valuation when considering expected earnings growth, compared to CBSH's PEG ratio of 2.56 [5]. - UMBF's P/B ratio stands at 1.19, which is lower than CBSH's P/B ratio of 1.77, further supporting UMBF's valuation attractiveness [6]. Earnings Outlook - UMBF is currently experiencing an improving earnings outlook, which is a positive indicator in the Zacks Rank model, suggesting potential for better performance [3][7]. - The Zacks Rank for UMBF is 2 (Buy), while CBSH holds a Zacks Rank of 4 (Sell), indicating a stronger investment case for UMBF [3]. Value Grades - UMBF holds a Value grade of B, while CBSH has a Value grade of C, reflecting UMBF's superior valuation metrics [6].

Core Viewpoint - The market anticipates Adherex Technologies Inc. (FENC) will report a year-over-year increase in earnings driven by higher revenues in its upcoming earnings report for the quarter ended December 2025 [1] Earnings Expectations - The consensus estimate for quarterly earnings is $0.03 per share, reflecting a year-over-year increase of +150% [3] - Expected revenues are $14.97 million, which is an increase of 88.8% compared to the same quarter last year [3] Estimate Revisions - The consensus EPS estimate has been revised 403.57% higher in the last 30 days, indicating a significant reassessment by analysts [4] - The Most Accurate Estimate for Adherex Technologies is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +140.00% [12] Earnings Surprise Prediction - A positive Earnings ESP reading suggests a likely earnings beat, especially when combined with a Zacks Rank of 1 (Strong Buy), 2 (Buy), or 3 (Hold) [10] - Adherex Technologies currently holds a Zacks Rank of 3, indicating a potential to beat the consensus EPS estimate [12] Historical Performance - In the last reported quarter, Adherex Technologies was expected to post a loss of $0.08 per share but instead reported a loss of -$0.02, resulting in a surprise of +75.00% [13] - Over the past four quarters, the company has exceeded consensus EPS estimates two times [14] Conclusion - Adherex Technologies is positioned as a compelling candidate for an earnings beat, but investors should consider additional factors before making investment decisions [17]

Core Viewpoint - Wall Street anticipates a year-over-year increase in Oracle's earnings driven by higher revenues, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - Oracle is expected to report quarterly earnings of $1.70 per share, reflecting a +15.7% change year-over-year [3]. - Revenues are projected to reach $16.89 billion, marking a 19.5% increase from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analyst expectations [4]. - A positive Earnings ESP of +1.12% suggests analysts have recently become more optimistic about Oracle's earnings prospects [12]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive reading is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [10]. - Oracle currently holds a Zacks Rank of 3, which, along with the positive Earnings ESP, suggests a likelihood of beating the consensus EPS estimate [12]. Historical Performance - In the last reported quarter, Oracle exceeded the expected earnings of $1.63 per share by delivering $2.26, resulting in a surprise of +38.65% [13]. - Over the past four quarters, Oracle has beaten consensus EPS estimates two times [14]. Conclusion - While Oracle is positioned as a compelling earnings-beat candidate, other factors should also be considered when evaluating the stock ahead of its earnings release [17].

Core Viewpoint - The market anticipates ARS Pharmaceuticals, Inc. (SPRY) will report a year-over-year decline in earnings due to lower revenues, with a focus on how actual results compare to estimates [1][2]. Earnings Expectations - The consensus EPS estimate for ARS Pharmaceuticals is a loss of $0.42 per share, reflecting a year-over-year change of -180.8% [3]. - Expected revenues for the upcoming quarter are $25.74 million, down 70.3% from the same quarter last year [3]. Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised 6.5% lower, indicating a reassessment by analysts [4]. - The Most Accurate Estimate for ARS Pharmaceuticals is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +39.90% [12]. Earnings Surprise Prediction - A positive Earnings ESP reading suggests a likely earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [10]. - The current Zacks Rank for ARS Pharmaceuticals is 3, indicating a potential for beating the consensus EPS estimate [12]. Historical Performance - In the last reported quarter, ARS Pharmaceuticals was expected to post a loss of $0.45 per share but actually reported a loss of -$0.52, resulting in a surprise of -15.56% [13]. - Over the past four quarters, the company has only beaten consensus EPS estimates once [14]. Industry Context - Another company in the Zacks Medical - Drugs industry, Profound Medical (PROF), is expected to post a loss of $0.27 per share, indicating a year-over-year change of -35% [18]. - Profound Medical's revenues are expected to be $7.65 million, up 83% from the previous year [18].

Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for Heritage Insurance (HRTG) due to higher revenues, with a focus on how actual results compare to estimates impacting stock price [1][2]. Earnings Expectations - The upcoming earnings report is expected on March 9, with a consensus EPS estimate of $1.61, reflecting a year-over-year increase of +143.9%. Revenues are projected at $212.61 million, up 1.1% from the previous year [3]. Estimate Revisions - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analyst expectations [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model shows a positive Earnings ESP of +24.61% for Heritage Insurance, suggesting analysts have recently become more optimistic about the company's earnings prospects [12]. Historical Performance - Heritage Insurance has a strong earnings surprise history, having beaten consensus EPS estimates in the last four quarters, including a notable surprise of +207.55% in the last reported quarter [13][14]. Investment Considerations - While Heritage Insurance is viewed as a strong candidate for an earnings beat, investors are advised to consider other factors that may influence stock performance beyond just earnings results [15][17].

Roku (ROKU) closed the last trading session at $98.41, gaining 3.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $125.36 indicates a 27.4% upside potential.The mean estimate comprises 28 short-term price targets with a standard deviation of $17.23. While the lowest estimate of $93.00 indicates a 5.5% decline from the current price level, the most optimistic analyst expects the s ...

Company Overview - Arrow Electronics Inc. is one of the world's largest distributors of electronic components and enterprise computing products, offering a broad product range and value-added services to enhance customer competitiveness [11]. Investment Rating - Arrow Electronics holds a 1 (Strong Buy) rating on the Zacks Rank, indicating strong potential for investment [12]. Style Scores - The company has a VGM Score of B, indicating a favorable combination of value, growth, and momentum characteristics [12]. - Arrow Electronics has a Momentum Style Score of B, with shares increasing by 14.9% over the past four weeks [12]. Earnings Estimates - For fiscal 2026, four analysts have revised their earnings estimates upwards in the last 60 days, with the Zacks Consensus Estimate increasing by $1.34 to $13.24 per share [12]. - The company boasts an average earnings surprise of +17.9%, suggesting strong performance relative to expectations [12]. Conclusion - With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, Arrow Electronics is positioned as a strong candidate for investors [13].

Company Overview - Mercury General is an insurance holding company headquartered in Los Angeles, CA, founded in 1961, primarily engaged in writing personal automobile lines of business and providing related property and casualty insurance products through 12 subsidiaries in 11 states, mainly in California [11] - The company reported approximately $5.9 billion in direct premiums written in 2025, with private passenger automobile lines accounting for about 60% of this total, and 86% of these premiums were written in California [11] Investment Highlights - Mercury General holds a 1 (Strong Buy) rating on the Zacks Rank, indicating strong investment potential [12] - The company has a VGM Score of A, reflecting its attractiveness based on value, growth, and momentum characteristics [12] - The Momentum Style Score for Mercury General is also rated A, with shares increasing by 3.4% over the past four weeks [12] - An analyst has revised their earnings estimate higher for fiscal 2026, with the Zacks Consensus Estimate increasing by $0.60 to $9.00 per share [12] - Mercury General has an average earnings surprise of +55.1%, further indicating strong performance potential [12] Conclusion - With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, Mercury General is positioned as a strong candidate for investors looking for opportunities in the finance sector [13]

Core Insights - Zacks Premium provides tools for investors to enhance their stock market engagement and confidence through various resources [1] Zacks Style Scores - Zacks Style Scores are indicators that assist investors in selecting stocks likely to outperform the market within 30 days, rated from A to F based on value, growth, and momentum characteristics [2] - The Value Score identifies undervalued stocks using ratios like P/E, PEG, and Price/Sales to find attractive investment opportunities [3] - The Growth Score focuses on a company's future prospects by analyzing projected and historical earnings, sales, and cash flow to identify sustainable growth stocks [4] - The Momentum Score helps investors capitalize on price trends by assessing recent price changes and earnings estimate revisions [5] - The VGM Score combines all three Style Scores, providing a comprehensive indicator for evaluating stocks based on value, growth, and momentum [6] Zacks Rank - The Zacks Rank is a proprietary model that uses earnings estimate revisions to simplify portfolio building, with 1 (Strong Buy) stocks achieving an average annual return of +23.86% since 1988, significantly outperforming the S&P 500 [7] - There are typically over 800 top-rated stocks available, making it essential to utilize Style Scores to narrow down choices [8] - Investors should prioritize stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B to maximize potential upside [9] - Stocks rated 4 (Sell) or 5 (Strong Sell) may still have high Style Scores but are likely to decline due to negative earnings forecasts [10] Company Spotlight: ATI Inc. - ATI Inc., based in Pittsburgh, PA, is a diversified specialty materials producer with a Zacks Rank of 2 (Buy) and a VGM Score of B [11] - The company is particularly appealing to growth investors, with a Growth Style Score of A and a forecasted year-over-year earnings growth of 27.2% for the current fiscal year [12] - Recent earnings estimates for fiscal 2026 have been revised upward, with the Zacks Consensus Estimate increasing by $0.17 to $4.12 per share, alongside an average earnings surprise of +11.2% [12]

Core Insights - The Zacks Style Scores are designed to help investors select stocks with the highest potential to outperform the market over the next 30 days, using an alphabetic rating system from A to F based on value, growth, and momentum qualities [2][10]. Value Score - The Value Style Score focuses on identifying stocks that are undervalued relative to their true worth, utilizing financial ratios such as P/E, PEG, Price/Sales, and Price/Cash Flow to highlight attractive investment opportunities [3]. Growth Score - The Growth Style Score emphasizes a company's financial health and future growth potential, analyzing projected and historical earnings, sales, and cash flow to identify stocks with sustainable long-term growth [4]. Momentum Score - The Momentum Style Score assists investors in capitalizing on price trends, using metrics like one-week price changes and monthly earnings estimate changes to determine optimal entry points for stocks [5]. VGM Score - The VGM Score combines the Value, Growth, and Momentum Scores into a single metric, helping investors find stocks with the best overall characteristics for value, growth forecasts, and momentum [6]. Zacks Rank - The Zacks Rank is a proprietary stock-rating model that leverages earnings estimate revisions to guide investors in building successful portfolios, with 1 (Strong Buy) stocks historically yielding an average annual return of +23.86% since 1988, significantly outperforming the S&P 500 [7][8]. Stock Selection Strategy - To maximize returns, investors should target stocks with a Zacks Rank of 1 or 2 that also possess Style Scores of A or B, while stocks with a 3 (Hold) rank should also have high Style Scores to ensure potential upside [10][11]. Company Spotlight: Henry Schein Inc. - Henry Schein Inc., based in Melville, NY, is a leading distributor of healthcare products and services, operating in 33 countries and serving various healthcare practitioners and institutions [12]. - Currently rated 3 (Hold) by Zacks, Henry Schein has a VGM Score of A and a Growth Style Score of A, with a projected year-over-year earnings growth of 6.6% for the current fiscal year [12][13]. - Recent upward revisions in earnings estimates by analysts indicate a positive outlook, with the Zacks Consensus Estimate increasing by $0.03 to $5.30 per share, and an average earnings surprise of +2.1% [13].